Don Madison
Analyst · Stifel. Please go ahead
Thank you, Mike. Revenues increased 5% or $8 million to $170 million in the second quarter compared to the second quarter fiscal '14. Domestic revenues increased by $29 million or 31% to $120 million in the second quarter. The increase in domestic revenues was primarily driven by our backlog of petrochemical projects. International revenues decreased by $21 million or 29% to $50 million. The decrease in international revenues was driven primarily by the substantial completion of a large project last year. Gross profit as a percentage of revenues decreased to 14.3% in the second quarter of fiscal '15 compared to 21.5% in the second quarter of fiscal '14. This decrease in gross profit was primarily driven by the margins associated with the mix of projects in process and continued inefficiencies and incremental cost associated with the expansion and stabilization of our Canadian operations. Selling, general and administrative expenses decreased by $2.6 million to $19 million in the second quarter. Primarily due to reductions performance based compensation partially offset by increased personnel and administrative cost associated with the expansion of our operations in Canada. SG&A expenses as a percentage of revenues decreased to 11.4% in the second quarter compared to 13.6% in the second quarter a year ago. And the second quarter of fiscal '15, we incurred approximately $1.3 million or $900,000 net of income taxes in restructuring and separation cost. We've recorded provision for income taxes of $6.4 million compared to provision of $4.1 million in the second quarter of fiscal '14. The effective tax rate for the second quarter was 237% compared to an effective tax rate of 37% in the second quarter of fiscal '14. In the second quarter of fiscal '15, we recorded a $9 million valuation allowance against our Canadian deferred tax assets, which is partially offset by the release of a $4.1 million R&D tax credit reserve on the closing of an IRS audit The net impact of these two items was $4.9 million, increase to our tax provision and a corresponding $4.9 million reduction through net income. I would like to take a moment to discuss these two tax issue in more detail. First the income tax valuation allowance, you may recall in fiscal 2010 we recorded valuation allowance in Canada. This was a result of a first year loss following our acquisition. Following a period of time, we turn the business around and we’re generating profits. As a result, we were able to reverse the valuation allowance at the end of fiscal '13. As we move into our new Canadian facility, we encountered high operating cost as we work to higher trained and stabilized a much larger workforce on an aggressive schedule driven by market demand. As a result, we have been operating at a loss and will require to re-establish our valuation allowance. Once we return to a position of consistent profitability, we will be able to reverse this allowance. The second item is an R&D reserve. A few years ago, we engaged a third-party consultant to review our R&D expenses and our tax position related to as R&D tax credits. Based on the outcome of this study, we determined that we should [remain] prior year returns and claim larger credits going forward. We parse the reserves for a larger tax credit position until we completed an IRS audit. This audit was completed this past quarter allowing us to release a $4.1 million reserve. In the second quarter of fiscal '15, we reported a net loss from continuing operations of $3.7 million, $0.31 per diluted share, compared to net income of $7 million or $0.58 per diluted share a year ago. Excluding the second quarter, tax adjustments and restructuring costs, net income of the second quarter of fiscal '15 was $2 million or $0.17 per diluted share. For the six months ended March 31, 2015, revenues increased 3% or $11 million to $323 million, compared to same period a year ago. Gross profit as a percentage of revenues was 14% compared to 21% in the first six months of fiscal '14. This decrease in gross profit is primarily due to cost associated with our Canadian operations, as well as the overall mix of projects. Selling, general and administrative expenses decreased by $3 million to $40 million compared to the first six months of fiscal '14, primarily due to a reduction in performance based compensation and overall cost saving measures. At the six months ended March 31, 2015, we incurred approximately $1.3 million or $900,000 net of income taxes in restructuring and separation cost. And we recorded provision for income taxes of $5.4 million for the six months ended March 31, 2015 compared to the provision of $8 million the same period a year ago. Included in current year provision as Canadian tax valuation allowance which is partially offset by the release of an R&D tax credit reserve I discussed earlier. For the six months ended March 31, 2015, we reported a net loss from continuing operations of $3.9 million or $0.33 per diluted share, compared to net income of $14.2 million or $1.18 per diluted share a year ago. Excluding the tax and restructuring charges that occurred in the second quarter net income for the first-half of fiscal '15 was $1.8 million or $0.15 per diluted share. New orders for the second quarter were $167 million compared -- resulting in a backlog of $499 million, compared to a backlog of $506 million at the end of the prior quarter and $452 million a year ago. At March 31, 2015, we had cash of $56 million compared to $103 million at September 30, 2014. For the six months of fiscal '15, cash used by operating activities totaled $4 million and investments in property plant and equipments totaled approximately $29 million. Through March 31st, we repurchased 171,000 shares at an average price of $33.60 per share for a total of $5.8 million. Amounts remaining available under the company’s current share repurchase authorization totaled $19.2 million which is scheduled to expire on December 31, 2015. During the same period, we paid dividends totaling $6.3 million. And long-term debt and capital lease obligations prudent current maturities totaled $3 million at March 31, 2015. Looking ahead, based on our backlog and current business conditions, we expect full year fiscal '15 revenues to range between $625 million and $675 million, unchanged from our previous guidance. And we expect adjusted earnings to range between $1.25 and the $1.50 per share compared to our previous guidance of $1.25 to $1.75 per share. Our earnings guidance excludes tax adjustments and restructuring charges. We reported $900,000 of restructuring cost in the second quarter and we're currently evaluating additional restructuring that may be needed to in line our operating cost with market conditions. At this point Mike and I will be happy to answer your questions.